The FDA has issued a final rule permitting the use of salt substitutes in standardized foods to reduce sodium content. The rule amends 80 standards of identity to allow manufacturers flexibility in producing lower-sodium products.
By Hermes-Vector AI Desk
The Food and Drug Administration (FDA) has issued a final rule to amend its standard of identity regulations, permitting the use of salt substitutes in standardized foods. The action aims to reduce sodium content in the food supply, which may help lower the risk of hypertension, a major risk factor for heart disease and stroke.
The final rule amends 80 standards of identity (SOI) that specify salt (sodium chloride) as a required or optional ingredient. By creating a new subpart titled "Flexibility in Standardized Foods" within the regulation "Food Standards: General" (21 CFR part 130), the FDA defines salt substitutes and allows their use in these foods. The rule does not list specific salt substitutes; instead, it generally allows ingredients or combinations of ingredients to be used as salt substitutes by manufacturers currently or in the future, provided they are safe and suitable.
The rule applies to foods for which the FDA has established SOI, referred to as "standardized foods." The amendments are designed to provide flexibility to facilitate industry innovation in the production of standardized foods lower in sodium while maintaining the basic nature and essential characteristics of the foods. The FDA states that reducing sodium consumption may help reduce the risk of hypertension and improve consumer dietary patterns.
The FDA is issuing this rule under sections 201, 401, 402, and 701 of the Federal Food, Drug, and Cosmetic Act (FD&C Act). The agency notes that ingredients added to standardized foods must still comply with other requirements of the FD&C Act, including pre-market review and approval requirements for food additives under section 409. The rulemaking does not provide an authorization or an exemption from regulation as a food additive.
The rule is effective 60 days after the date of publication in the Federal Register. Objections or requests for a hearing on amendments to standards of identity for dairy products in parts 131 and 133 must be submitted within 30 days after the date of publication.
According to the FDA, there are no regulatory costs associated with the final rule because there are no regulatory requirements or penalties if manufacturers choose not to use salt substitutes. The agency qualitatively discusses potential costs from voluntary reformulation and re-labeling, as well as potential consumer dissatisfaction with altered product properties. The benefits are described as increased flexibility for manufacturers and potential public health benefits from decreased sodium consumption.
The FDA references the Dietary Guidelines for Americans, which state that the general population, ages 14 and above, should consume less than 2,300 milligrams per day of sodium. The rule supports the Make America Healthy Again initiative by providing manufacturers flexibility to innovate and make more healthful, lower-sodium foods.
This rule removes regulatory barriers that previously prevented manufacturers from using salt substitutes in standardized foods. While manufacturers could already use salt substitutes in non-standardized foods, the previous standards of identity precluded their use in many common products. By allowing this flexibility, the FDA aims to support voluntary industry efforts toward sodium reduction and provide consumers with more choices for lower-sodium varieties of foods.
Sources
This article was drafted with AI assistance and checked against the sources above. Company claims are reported as claims. Cover image is AI-generated.
The day's checked news, by email
One short email a day with the top stories. Free, and you can unsubscribe in one click.
Or follow for the latest news:
CDC data confirms over 4,000 measles cases in the US, with most infections among unvaccinated individuals. Pennsylvania reports five deaths, while New York declares a state of emergency.
Pacific Health Sciences is voluntarily recalling one lot of Babies' Magic Tea Baby Sleep Gripe Water after FDA testing found undeclared ethanol, methanol and isopropanol.
